Event 
Partner 
Milestone 
2018-07-01
June 12 ACT Genomics at the Government House
ACT Genomics was invited to attend InvestHK’s Reception for New Foreign and Mainland Companies in Hong Kong at the Government House on June 12th, 2018.
Place:
Hong Kong
2018-07-01
June 08-09 Knowledge Transfer and Networking Opportunity at the 5th Macau Symposium on Biomedical Sciences
ACT Genomics was invited to participate at the “Precision” symposium, organized by the Faculty of Health Sciences at the University of Macau, from June 8th to 9th.
Place:
Macau
2018-07-01
June 05 Seminar on Next-Generation Sequencing in Cancer Treatment at Queen Elizabeth Hospital
ACT Genomics sponsored a seminar entitled “The Coming Era of Precision Oncology – The importance of Next-Generation Sequencing (NGS) Testing in Cancer Patient Treatment” at Queen Elizabeth Hospital on June 5th, 2018.
Place:
Hong Kong
2018-07-01
May 30 Liaison with the University of Macau - Potential Research Collaborations
ACT Genomics received a warm welcome by Prof. Deng Chuxia (Dean/Chair Professor of Faculty of Health Sciences, University of Macau) and his team on May 30th, 2018 in Macau.
Place:
Macau
2018-06-07
June 01-05 ACT Genomics research results accepted by 2018 ASCO
ACT Genomics is proud to have 4 abstracts accepted for publication at 2018 ASCO! The abstracts highlight our experiences in identifying actionable alterations across different solid tumors using comprehensive genomic profiling.
Place:
USA
2018-06-05
July 21-22 ACT Genomics introduces precision medicine in lung cancer workshop
A lung cancer workshop is held by Taiwan Society of Pulmonary and Critical Care Medicine in Taichung to explore the latest trend in lung cancer treatment. ACT Genomics will share more about precision medicine in our display area.
Place:
Taichung
2018-06-05
June 15-16 ACT Genomics Roundtable & Symposium Talk in Cebu, Philippines
ACT Genomics is honoured to be invited to give a roundtable & symposium talk in Cebu, Philippine
Place:
Philippines
2018-06-05
June 13-14 ACT Genomics is awarded the best immunotherapy solution provider in 2nd China & America Precision Medicine Forum 2018
ACT Genomics is awarded the best immunotherapy solution provider in 2nd China & America Precision Medicine Forum 2018 for its research achievements in immunotherapy. ACT Genomics CSO Dr. Shu-Jen Chen will deliver a talk to elaborate on the role and applic
Place:
Shanghai
2018-06-05
June 11 Visit us at Biomarker & Immuno-oncology World Congress 2018
Dr. Kien Thiam Tan will present ACT Genomics' newly developed TME (tumor microenvironment) profiling service, aimed to identify patients suitable for immune checkpoint inhibitors. Come visit us at booth #2!
Place:
USA
2018-06-05
June 03 ACT Genomics introduced precision medicine in Taiwan Bio Forum
ACT Genomics is honoured to introduce precision medicine in Taiwan Bio Forum co-organized by The Development Center for Biotechnology (DCB) and Monte Jade Science and Technology Association of New England (MJNE) in Boston.
Place:
USA
